Jasper Hellweg
Stock Analyst at Argus Research
(2.13)
# 2,931
Out of 4,996 analysts
88
Total ratings
48.61%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Reiterates: Buy | $190 | $143.50 | +32.40% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $137.37 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $432.66 | -7.55% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $91.69 | +63.59% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $45.54 | +31.75% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $563.90 | +107.48% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $385.74 | +42.58% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $73.76 | +15.24% | 3 | May 30, 2024 | |
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $55.61 | +124.78% | 1 | Feb 1, 2024 | |
| MRNA Moderna | Maintains: Buy | $160 → $140 | $24.49 | +471.66% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $220.61 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $18.34 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $179.56 | +61.51% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $101.50 | -1.48% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $280.61 | +5.13% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.91 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $188.99 | -28.57% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $21.98 | - | 2 | Sep 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $21.45 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $254.27 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $38.59 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $419.08 | -63.01% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $129.56 | -30.53% | 1 | Sep 19, 2018 |
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $143.50
Upside: +32.40%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $137.37
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $432.66
Upside: -7.55%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $91.69
Upside: +63.59%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $45.54
Upside: +31.75%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $563.90
Upside: +107.48%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $385.74
Upside: +42.58%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $73.76
Upside: +15.24%
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $55.61
Upside: +124.78%
Moderna
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $24.49
Upside: +471.66%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $220.61
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $18.34
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $179.56
Upside: +61.51%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $101.50
Upside: -1.48%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $280.61
Upside: +5.13%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.91
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $188.99
Upside: -28.57%
Sep 4, 2020
Downgrades: Hold
Price Target: n/a
Current: $21.98
Upside: -
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $21.45
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $254.27
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $38.59
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $419.08
Upside: -63.01%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $129.56
Upside: -30.53%